October 27, 2016 5:16 AM ET


Company Overview of AnaptysBio, Inc.

Key Executives for AnaptysBio, Inc.

NameBoard RelationshipsTitleAge
Hamza Suria M.Sc., MBA10 RelationshipsChief Executive Officer, President and Director40
Andrew B. Cubitt Ph.D.No RelationshipsCo-Founder53
Robert E. Hoffman CPA35 RelationshipsChief Financial Officer50
Margaret Marino No RelationshipsHead of Project Management--

AnaptysBio, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
James N. Topper M.D., Ph.D. 80 RelationshipsFrazier Healthcare Partners54
Hamza Suria M.Sc., MBA 10 RelationshipsAnaptysBio, Inc.40
Carol G. Gallagher Pharm.D 67 RelationshipsNew Enterprise Associates51
Hollings C. Renton III., M.B.A 36 RelationshipsPortola Pharmaceuticals, Inc.69
John P. Schmid 20 RelationshipsNeos Therapeutics, Inc.53
View All Board Members

AnaptysBio, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee John P. Schmid20 Relationships3 Executives
Compensation Committee Pharm.DCarol G. Gallagher67 Relationships2 Executives
Nominating Committee III., M.B.AHollings C. Renton36 Relationships3 Executives
Corporate Governance Committee III., M.B.AHollings C. Renton36 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Not meaningful
Total Value of Options$479.5K
Compensation as of Fiscal Year 2015
AnaptysBio, Inc. CEO Compensation
Industry Average


ChemoCentryx Promotes Susan M. Kanaya to Position of Executive Vice President, Chief Financial and Administrative Officer and Secretary
October 25, 2016 8:02 PM ET
China Regenerative Medicine International Limited Appoints Chen Chunguo as President, Effective October 25, 2016
October 25, 2016 10:35 AM ET
Agendia Announces Appointments to Medical Advisory Board
October 25, 2016 10:20 AM ET
Global Blood Therapeutics, Inc. Announces Resignation of Dr. Eleanor Ramos as Chief Medical Officer
October 24, 2016 8:34 PM ET
GenVec, Inc. Announces Board Changes
October 24, 2016 8:33 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact AnaptysBio, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.